Dietary Supplementation With 25-hydroxyvitamin D3 in Older Adults
NCT ID: NCT01398202
Last Updated: 2015-12-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
56 participants
INTERVENTIONAL
2011-01-31
2011-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vitamin D3 (20 microgram/day)
vitamin D3
20 micrograms per day for 10 weeks
25-hydroxyvitamin D (7 microgram/day)
25-hydroxyvitamin D3
7 microgram/day for 10 weeks
25-hydroxyvitamin D3 (20 micogram/day)
25-hydroxyvitamin D (20 microgram/day)
20 microgramday for 10 weeks
Placebo
Placebo
0 ug vitamin D3/25-hydroxyvitamin D3/day for 10 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
vitamin D3
20 micrograms per day for 10 weeks
25-hydroxyvitamin D3
7 microgram/day for 10 weeks
25-hydroxyvitamin D (20 microgram/day)
20 microgramday for 10 weeks
Placebo
0 ug vitamin D3/25-hydroxyvitamin D3/day for 10 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Body Mass Index (BMI) 19-30
Exclusion Criteria
* chronic illness
* renal or liver disorders
* taking medications that might interact with vitamin D or metabolite
* drank more than \> 21 standards (male)/ 14 standards (female) of alcohol per week
* planning to change smoking habits
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University College Cork
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kevin D. Cashman
Professor of Food and Health
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kevin D Cashman, PhD
Role: PRINCIPAL_INVESTIGATOR
University College Cork
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University College Cork
Cork, , Ireland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Cashman KD, Seamans KM, Lucey AJ, Stocklin E, Weber P, Kiely M, Hill TR. Relative effectiveness of oral 25-hydroxyvitamin D3 and vitamin D3 in raising wintertime serum 25-hydroxyvitamin D in older adults. Am J Clin Nutr. 2012 Jun;95(6):1350-6. doi: 10.3945/ajcn.111.031427. Epub 2012 May 2.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
111
Identifier Type: -
Identifier Source: org_study_id